Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01142323 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of Fenofibrate for PSC
A Phase 1 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT01142323: Clinical Trial Phase 1 study, sponsored by University of Miami.
NCT01142323 is a Phase 1 study that was terminated before completion, run by University of Miami. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01142323, a Phase 1 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether fenofibrate is safe and effective in the treatment primary sclerosing cholangitis (PSC).
Primary Outcome
Serum alkaline phosphatase will be measured at entry and end of study
Interventions
- DRUG fenofibrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Why NCT01142323 stopped before completion
NCT01142323 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which fenofibrate is the first listed.
NCT01142323 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01142323 about?
NCT01142323 is a clinical study titled "Pilot Study of Fenofibrate for PSC". The purpose of this study is to determine whether fenofibrate is safe and effective in the treatment primary sclerosing cholangitis (PSC).
What is the current status of trial NCT01142323?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2010-10. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01142323?
The interventions under investigation include: fenofibrate (DRUG).
Who is sponsoring clinical trial NCT01142323?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01142323's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia